Cardiovascular Disease

Ticagrelor Monotherapy Shows Cardiovascular Benefit in Patients with Diabetes

March 31, 2020

Ticagrelor alone, without aspirin, reduced bleeding without increasing the cardiovascular risks.

Alirocumab Evaluated for Treatment of Homozygous Familial Hypercholesterolemia

March 31, 2020

Alirocumab significantly reduced low-density lipoprotein cholesterol in adults with homozygous familial hypercholesterolemia, according to phase 3 data. 

FDA Grants Fast Track Designation to Empagliflozin for Chronic Kidney Disease

March 17, 2020

Empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) is being investigated to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.

Study Finds Habitual Fish Oil Use Linked to Cardiovascular Benefits

March 12, 2020

Fish oil supplementation may be associated with lower all-cause mortality, cardiovascular disease (CVD) mortality, and CVD events.

EHR Data Analysis Suggests Need for Improvement in Blood Pressure Management

March 11, 2020

A new study found several shortcomings in blood pressure management.

Benefits of Hypertension Treatments Largely Similar Across Drug Classes

February 26, 2020

The differences between antihypertension medication classes were generally small and nuanced in terms of their effect on reducing cardiovascular risks.

Analysis: Apixaban Associated with Lower Risks Than Warfarin

February 25, 2020

A secondary analysis presented at the American Stroke Association’s International Stroke Conference 2020 confirmed the safety of apixaban treatment.

FDA OKs New Non-Statin, LDL-C Lowering Treatment

February 24, 2020

Bempedoic acid (Nexletol, Esperion) is a new lipid-lowering therapy option for patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease.

Study Adds to Evidence Linking Rosiglitazone to Cardiovascular Risks

February 12, 2020

Rosiglitazone, which is used to treat type 2 diabetes, may increase the risk of heart problems.

Does Blood Pressure, Cholesterol Medication Use Affect Healthy Habits?

February 06, 2020

A new study shows that patients who initiated treatment with blood pressure or cholesterol medications were more likely to reduce activity and gain weight.